Immunophage Biotech
Shanghai
About Immunophage Biotech
Immunophage Biotech is a Chinese high-tech pharmaceutic company which was established in 2016. The R&D center of the company is located in the Pujiang High-Tech Park, Shanghai, China. They are developing first-in-class immune-regulating medicines against cancer, autoimmune diseases and neurodegenerative disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $74.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2023)
- Website: immunophage.com.cn
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/immunophage-biotech-71521 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.